A veteran investor and operator focused on private equity and growth-stage technology, with experience in deal execution, portfolio management and strategic operations. Scott Letson brings operating-senior leadership from technology and services companies to investment sourcing and value creation initiatives. He is known for hands-on post-acquisition oversight, commercial scaling and governance work with management teams. Background includes roles spanning corporate development, M&A and senior finance functions, and participation in leveraged and growth investments. Market-relevant strengths: transaction structuring, operational turnarounds and board-level oversight; sector focus on enterprise software, fintech and B2B services.
A veteran investor and operator focused on private equity and growth-stage technology, with experience in deal execution, portfolio management and strategic operations. Scott Letson brings operating-senior leadership from technology and services companies to investment sourcing and value creation initiatives. He is known for hands-on post-acquisition oversight, commercial scaling and governance work with management teams. Background includes roles spanning corporate development, M&A and senior finance functions, and participation in leveraged and growth investments. Market-relevant strengths: transaction structuring, operational turnarounds and board-level oversight; sector focus on enterprise software, fintech and B2B services.
Combines private equity rigor with operating instincts, prioritizing investments in enterprise software, fintech and B2B services where operational improvements can drive outsized value. Focuses on growth-stage and buyout situations that benefit from hands-on commercial scaling, governance upgrades and transaction structuring creativity. Deploys capital with a bias toward control or strong governance rights, uses active board oversight and metric-driven performance plans, and pursues multi-year value creation through margin expansion, product-market fit acceleration, and targeted M&A or tuck-ins.
Combines private equity rigor with operating instincts, prioritizing investments in enterprise software, fintech and B2B services where operational improvements can drive outsized value. Focuses on growth-stage and buyout situations that benefit from hands-on commercial scaling, governance upgrades and transaction structuring creativity. Deploys capital with a bias toward control or strong governance rights, uses active board oversight and metric-driven performance plans, and pursues multi-year value creation through margin expansion, product-market fit acceleration, and targeted M&A or tuck-ins.
| Trades 532 | Longs Won 352/532 66% | Profit Factor 3.61 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $797,139.67 |
| Average Win $219,297.91 | Best Trade (Aug 20) $12.07M | Sharpe Ratio -13.15 |
| Average Loss -$118,938.86 | Worst Trade (Aug 07) -$6.81M | Z-Score 5.85 (100%) |
| Commissions $0 | Avg. Trade Length 1y 7m 1w 3d | Expectancy $104,856.9 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | 0.01% |
| Consecutive Losing Trades | 2,387 | 2,148 | 1,909 | 1,671 | 1,432 | 1,193 | 955 | 716 | 477 | 239 |
| Symbol | Quantity | Cost | Value | Comm. | Profit ($) | Gain (%) | Change |
|---|---|---|---|---|---|---|---|
AAPL Apple Inc. | 1,612 | $339,745.21 | $503,604.92 | - | $163,859.71 | 48.23% | +0.453% |
ABBV AbbVie Inc. | 110,947 | $17.27M | $27.05M | - | $9.78M | 56.6% | -0.975% |
ABT Abbott Laboratories | 108,640 | $11.97M | $11.46M | - | -$508,355.29 | -4.25% | -0.236% |
ACN Accenture plc Class A | 43,265 | $14.9M | $7.4M | - | -$7.49M | -50.3% | +0.223% |
ADP Automatic Data Processing Inc. | 22,916 | $5.28M | $6.19M | - | $909,922.89 | 17.24% | 0.0 |
AFL Aflac Inc. | 3,788 | $314,042.73 | $475,621.28 | - | $161,578.55 | 51.45% | 0.0 |
ALB Albemarle Corporation | 1,860 | $263,078 | $233,281.2 | - | -$29,796.8 | -11.33% | +5.537% |
AMGN Amgen Inc. | 13,001 | $3.75M | $5.07M | - | $1.32M | 35.13% | -4.367% |
AMP Ameriprise Financial, Inc. | 3,381 | $1.28M | $1.87M | - | $587,449.05 | 45.74% | -1.328% |
AMZN Amazon.com Inc | 1,003 | $220,229 | $273,076.78 | - | $52,847.78 | 24% | -0.143% |
ANET Arista Networks, Inc. | 3,000 | $232,440 | $576,960 | - | $344,520 | 148.22% | -2.529% |
APD Air Products and Chemicals, Inc. | 1,476 | $404,129 | $434,991.95 | - | $30,862.95 | 7.64% | -0.129% |
APH Amphenol Corporation | 3,858 | $238,713.75 | $330,495.57 | - | $91,781.82 | 38.45% | -0.528% |
ASML ASML Holding N.V. New York Registry Shares | 376 | $284,601.92 | $631,010.71 | - | $346,408.79 | 121.72% | 0.0 |
AVGO Broadcom Inc. | 6,580 | $734,492.5 | $2.79M | - | $2.06M | 280.49% | +1.54% |
AXP American Express Company | 31,240 | $5.88M | $10.83M | - | $4.95M | 84.29% | -0.653% |
BAC Bank of America Corporation | 107,967 | $3.69M | $6.83M | - | $3.14M | 84.99% | 0.0 |
BATRA Atlanta Braves Holdings, Inc. Series A Common Stock | 4,000 | $225,240 | $217,640 | - | -$7,600 | -3.37% | +3.088% |
BDX Becton, Dickinson and Company | 13,582 | $2.6M | $2.43M | - | -$175,003.54 | -6.73% | +4.653% |
BMY Bristol-Myers Squibb Company | 16,493 | $846,256.04 | $1.06M | - | $211,769.91 | 25.02% | +0.817% |